Charles River Laboratories International (CRL) Consolidated Net Income (2009 - 2026)

Charles River Laboratories International has reported Consolidated Net Income for 18 years, with the latest figure at -$760000.0 in Q2 2026.

• On a quarterly basis, Consolidated Net Income fell 101.44% year-over-year to -$760000.0 in Q2 2026; TTM through Jun 2026 was -$236.3 million, a 264.2% decrease from a year earlier, with the FY2025 full-year figure at -$142.2 million, down 662.11% from the prior year.
• Consolidated Net Income was -$760000.0 for Q2 2026 at Charles River Laboratories International, up from -$14.8 million in the prior quarter.
• The five-year high for Consolidated Net Income was $189.1 million in Q4 2022, with the low at -$276.3 million in Q4 2025.
• Average Consolidated Net Income over 5 years is $46.7 million, with a median of $81.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Consolidated Net Income soared 48.94% in 2022, then tumbled 213.12% in 2024.
• Over 5 years, Consolidated Net Income stood at $189.1 million in 2022, then slipped by 0.08% to $189.0 million in 2023, then sank by 213.12% to -$213.7 million in 2024, then slipped by 29.26% to -$276.3 million in 2025, then jumped by 99.72% to -$760000.0 in 2026.
• The last three Consolidated Net Income figures came in at -$760000.0 (Q2 2026), -$14.8 million (Q1 2026), and -$276.3 million (Q4 2025), per Business Quant data.